Cardiovascular disease is responsible for significant morbidity and mortality in renal failure with increased prevalence of hypertension, left ventricular hypertrophy, ischaemic heart disease and valve disease. Optimum blood pressure control is fundamental to the management of these patients but the role of secondary prevention remains poorly defined.